摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N'-{di(pyridin-2-yl)methylene}picolinohydrazide | 42838-32-4

中文名称
——
中文别名
——
英文名称
N'-{di(pyridin-2-yl)methylene}picolinohydrazide
英文别名
pyridine-2-carboxylic acid (di-pyridin-2-yl-methylene)-hydrazide;N-(dipyridin-2-ylmethylideneamino)pyridine-2-carboxamide
N'-{di(pyridin-2-yl)methylene}picolinohydrazide化学式
CAS
42838-32-4
化学式
C17H13N5O
mdl
——
分子量
303.323
InChiKey
QFUVMEGEHMVCHT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    23
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    80.1
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    manganese(II) perchlorate hexahydrate 、 N'-{di(pyridin-2-yl)methylene}picolinohydrazide甲醇乙腈 为溶剂, 以52%的产率得到
    参考文献:
    名称:
    一系列自组装多核Mn(II),Co(II)和Cu(II)簇配合物的合成,结构和磁性
    摘要:
    Mn(II),Co(II),Co(II)/ Co(III)和Cu(II)以及一组烷氧基的一系列自组装簇络合物的单晶结构和磁性据报道具有方形和矩形一级结构的二嗪配体。在一种新颖的情况下,由于存在空的核外配位位点,可以在方形核上建立金属离子的二级配位球。[Mn 4(poapz-H)4(H 2 O)4 ](NO 3)4 ·H 2 O(1); 单斜,C 2 / c,a = 21.7120(4)Å,b = 17.421(4)Å,c = 17.273(4)Å,β= 109.34(3)°。[Co 4(poap-H)2(poap-2H)2 ](NO 3)4 ·7H 2 O(3); 三斜晶,P,a = 9.6855(6)Å,b = 12.9462(7)Å,c = 13.7383(8)Å,α = 106.5730(10),β = 99.0400(10)Å,γ = 95.737(10)° 。[Co 4(poapz-H)4(H
    DOI:
    10.1006/jssc.2001.9160
点击查看最新优质反应信息

文献信息

  • Trinuclear copper(II) complexes with bridging (N–N) diazine ligands: structural and magnetic studies
    作者:Liang Zhao、Laurence K. Thompson、Zhiqiang Xu、David O. Miller、David R. Stirling
    DOI:10.1039/b008768h
    日期:——
    The polytopic ligands 2poap and po2p have a linear disposition of coordination pockets suitably disposed to bind metal ions in close proximity and produce linear trinuclear copper(II) complexes. The complexes [Cu3(2poap − 2H)(CH3CO2)4]·3H2O (1), [Cu3(2poap − 2H)(H2O)(DMF)3(CH3OH)2](BF4)4 (2), and [Cu3(po2p − H)2(H2O)2](ClO4)4·2H2O (3) have a linear arrangement of Cu(II) centres linked by a trans arrangement
    多主题 配体2poap和po2p具有线性排列的配位腔,适合于紧密结合属离子并生成线性三核(II)配合物。配合物[Cu 3(2poap-2H)(CH 3 CO 2)4 ]·3H 2 O(1),[Cu 3(2poap-2H)(H 2 O)(DMF )3(CH 3 OH)2 ] (BF 4)4(2)和[Cu 3(po2p-H)2(H 2 O)2 ](ClO 4)4 ·2H 2 O( 3)具有通过N–N单键的反式排列连接的Cu( II)中心线性排列。每种属都被指定为ad x 2  -  y 2 磁性基态,反之 二嗪 桥接结构导致强烈的反磁耦合,这与以前的磁性结构相关性完全一致,前者将围绕N–N键的磁性平面的扭曲与交换积分相关。
  • Synthesis and antibacterial studies of rhodium and iridium complexes comprising of dipyridyl hydrazones
    作者:Basava Punna Rao Aradhyula、Nidhi Joshi、Krishna Mohan Poluri、Mohan Rao Kollipara
    DOI:10.1016/j.molstruc.2018.03.058
    日期:2018.7
    ( 11 ) and Ir ( 12 )} which resulted in a series of mono- and di-nuclear cationic complexes. The complexes have been characterized by various spectroscopic techniques. The solid-state structures of three complexes (5, 6 and 8) have been determined by single-crystal X-ray diffraction studies. These cationic complexes have been evaluated for the preliminary antibacterial activity towards four bacterial
    摘要 Cp*Rh 和 Cp*Ir 二聚体与二吡啶,如吡啶甲酸 (L1)、烟碱 (L2) 和异烟碱 (L3) 的反应已在此处报道,配方 [Cp*MCl L3 ](PF 6 ) 其中M = Rh ( 5 ) 和 Ir ( 6 )}, [(Cp*MCl) 2 L1 ](PF 6 ) 其中 M = Rh ( 7 ) 和 Ir ( 8 )}, [(Cp*MCl) 2 L2 Cl ](PF 6 ) 其中 M = Rh( 9 ) 和 Ir( 10 )},和 [(Cp*MCl) 2 L3 Cl](PF 6 ) 其中 M = Rh ( 11 ) 和 Ir ( 12 )} 其中导致一系列单核和双核阳离子配合物。这些配合物已通过各种光谱技术表征。三种配合物(5、6 和 8)的固态结构已通过单晶 X 射线衍射研究确定。已经评估了这些阳离子复合物对四种细菌菌株的初步抗菌活性,即黄色葡萄球菌;苏云芽孢
  • Synthesis, structural, DFT studies and antibacterial evaluation of Cp∗ rhodium and Cp∗ iridium complexes using hydrazide based dipyridyl ketone ligand
    作者:A. Basava Punna Rao、Narasinga Rao Palepu、Debojit Kumar Deb、A. Uma、T. Chiranjeevi、Biplab Sarkar、Werner Kaminsky、Kollipara Mohan Rao
    DOI:10.1016/j.ica.2015.12.035
    日期:2016.3
    The synthesis, characterization and antibacterial evaluation of four new water soluble half-sandwich complexes of N'-di(pyridin-2-yl) methylene}picolinohydrazide (PHADPK-L1) and N'-di(pyridin-2-yl) methylene} nicotinohydrazide (NHADPK-L2) have been described with the general formula [Cp*MLCl] BF4 where L = L1, M = Rh (1), Ir (2); L = L2, M = Rh (3), Ir (4) have been described. All the complexes have been characterized by elemental analysis and spectral studies. Crystal structures of all the complexes 1-4 have been determined by single crystal X-ray analyses. Preliminary in vitro antibacterial activity of the four complexes was investigated against Gram-positive bacterium Staphylococcus aureus, and Gram-negative bacteria viz., Escherichia coli, Klebsiella pneumonia and Pseuedomonas aeruginosa by agar well diffusion method. Spectral and structural studies revealed that the formation of mononuclear complexes takes place by dipyridyl mediated N-N binding. All the complexes exhibited a HOMO (highest occupied molecular orbital)-LUMO (lowest unoccupied molecular orbital) energy gap from 3.65 to 3.97 eV. (C) 2016 Elsevier B.V. All rights reserved.
  • USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS
    申请人:Wagner Barbara
    公开号:US20110021407A1
    公开(公告)日:2011-01-27
    The present invention relates to the use of metal complex compounds having hydrazide ligands as oxidation catalysts. Further aspects of the invention are formulations comprising such metal complex compounds, novel metal complex compounds and novel ligands. The metal complex compounds are used especially for enhancing the action of peroxides, for example in the treatment of textile material, without at the same time causing any appreciable damage to fibres and dyeings. There is also no appreciable damage to fibres and dyeings if these metal complexes are used in combination with an enzyme or a mixture of enzymes.
  • US7928049B2
    申请人:——
    公开号:US7928049B2
    公开(公告)日:2011-04-19
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S,2'S)-(-)-[N,N'-双(2-吡啶基甲基]-2,2'-联吡咯烷双(乙腈)铁(II)六氟锑酸盐 (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 (1'R,2'S)-尼古丁1,1'-Di-N-氧化物 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸氯苯那敏-D6 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 韦德伊斯试剂 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非布索坦杂质66 非尼拉朵 非尼拉敏 雷索替丁 阿雷地平 阿瑞洛莫 阿扎那韦中间体 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 镉,二碘四(4-甲基吡啶)- 锌,二溴二[4-吡啶羧硫代酸(2-吡啶基亚甲基)酰肼]-